Results 21 to 30 of about 12,327 (198)

An investigation into the pathogenesis of vulvo-vaginal candidosis [PDF]

open access: yes, 2001
OBJECTIVE: To monitor yeasts isolated from women during and between episodes of recurrent vulvo-vaginal candidosis (VVC) to determine whether vaginal relapse or re-infection occurred. METHODS:Women presenting at the genitourinary medicine clinic with
Ashbee, H.R.   +4 more
core   +2 more sources

A multifunctional, synthetic Gaussia princeps luciferase reporter for live imaging of Candida albicans infections [PDF]

open access: yes, 2009
Peer reviewedPublisher ...
Brown, Alistair J P   +7 more
core   +3 more sources

Microbiological reasoning of the formation and development of vulvovaginal candidiasis

open access: yesZaporožskij Medicinskij Žurnal, 2017
Aim. To conduct microbiological reasoning of the formation and development of vulvovaginal candidiasis. To study taxonomic composition and major microbiota and yeast-like fungi of genus Candida and their changes in vulvovaginal content of women with ...
N. D. Yakovychuk   +5 more
doaj   +1 more source

Study of vulvovaginal candidiasis in symptomatic women of reproductive age group attending tertiary care institute, Haryana province

open access: yesAsian Journal of Medical Sciences, 2021
Background: Abnormal vaginal discharge results from a variety of infectious and noninfectious causes. Vulvovaginal candidiasis (VVC) is caused by the overgrowth of Candida species in the vagina and is characterized by itching, erythema and curd like ...
Gulnar K , Harman Multani
doaj   +1 more source

Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors [PDF]

open access: yes, 2016
Vulvovaginal candidiasis (VVC) is an infection caused by Candida species that affects millions of women every year. Although Candida albicans is the main cause of VVC, the identification of non-Candida albicans Candida (NCAC) species, especially Candida ...
Alves, Carlos   +5 more
core   +1 more source

α-galactosylceramide-stimulated invariant natural killer T-cells play a protective role in murine vulvovaginal candidiasis by Candida albicans.

open access: yesPLoS ONE, 2021
BackgroundVulvovaginal candidiasis is a common superficial candidiasis; however, a host's immunological mechanism against vaginal Candida infection remains unknown.ObjectivesIn this study, we aimed to elucidate the effect of iNKT cell activation on ...
Masahiro Abe   +6 more
doaj   +2 more sources

Recurrent urogenital candidiasis: diagnosis and treatment

open access: yesМедицинский совет, 2015
Vulvovaginal candidiasis is the most common manifestation of urogenital candidiasis. The disease is widespread among women of reproductive age. The disease recurs in 5-10% of cases.
A. M. Savicheva, E. V. Shipitsyna
doaj   +1 more source

Investigation of the relationship between different Candida species and some risk factors affecting the incidence of Vulvovaginal Candidiasis [PDF]

open access: yesMajallah-i Zanān, Māmā̓ī va Nāzā̓ī-i Īrān, 2019
Introduction: Vulvovaginal candidiasis (VVC) is a yeast infection and is one of the most common causes of women's referral to the physician. The aim of this study was to investigate the relationship between different Candida species and some risk factors
Seyedeh Sedigheh Hosseini   +11 more
doaj   +1 more source

Comparison of vaginal ointment of honey and clotrimazole for treatment of vulvovaginal candidiasis: A random clinical trial [PDF]

open access: yes, 2017
BACKGROUND AND OBJECTIVE: Vulvovaginal candidiasis (VVC) is the most prevalent vaginitis in women, accounting for 10 million medical referrals a year. Vaginal clotrimazole is a drug of choice for VVC treatment. However, increased drug resistance to this
Banaeian-Borujeni, Shayesteh   +4 more
core   +1 more source

Is it possible to prevent recurrent vulvovaginitis? The role of Lactobacillus plantarum I1001 (CECT7504) [PDF]

open access: yes, 2016
The online version of this article (doi:10.1007/s10096-016-2715-8) contains supplementary material, which is available to authorized ...
C. Prieto   +4 more
core   +2 more sources

Home - About - Disclaimer - Privacy